Product
mRNA-1283
2 clinical trials
1 indication
Indication
COVID-19Clinical trial
A Phase 2A, Randomized, Stratified, Observer-Blind Study to Evaluate the Immunogenicity and Safety of mRNA-1283 Vaccine Boosters for SARS-CoV-2Status: Completed, Estimated PCD: 2023-03-23
Clinical trial
A Phase 1, Randomized, Observer-Blind, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18-55 YearsStatus: Completed, Estimated PCD: 2023-07-25